Wednesday, July 3, 2013

New Report: PharmaPoint - Seasonal Influenza Vaccines India Drug Forecast and Market Analysis : MarketResearchReports.Biz

GlobalData has released its new Country report, PharmaPoint: Seasonal Influenza Vaccines India Drug Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently, trivalent intramuscular vaccines such as Sanofis Fluzone and Vaxigrip, GlaxoSmithKlines Fluarix and FluLaval and Novartis Fluvirin garner the majority stake of the market. However, with the entrance of vaccines with novel routes of administration, such as AstraZenecas intranasal FluMist and Sanofis Fluzone IntraDermal, GlobalData projects a dramatic shift favoring the adoption of such vaccines over the traditional intramuscular vaccines. GlobalData also anticipates that manufacturers that launch quadrivalent formulations will steal market share, patient share, and revenue from the trivalent influenza vaccines currently available.

The Indian influenza vaccine market is valued at $71 million for 2012. The market is forecast to grow slightly during the forecast period due to numerous market barriers overpowering any drivers of growth. Lack of a centralized healthcare policy regarding vaccination and limited awareness of the burden and threat of influenza among both Indian physicians and patients are examples of things hindering the growth of the influenza vaccine market in India.


  • Overview of seasonal influenza, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
  • Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis.
  • Sales forecast for the top drugs in India from 2012 to 2022.
  • Analysis of the impact of key events as well the drivers and restraints affecting the India seasonal influenza market.

To Buy The Copy of This Report Visit:

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

No comments:

Post a Comment